A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
NCT ID: NCT00306215
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
436 participants
INTERVENTIONAL
2006-03-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
NCT00102921
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
NCT01203631
A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease
NCT03681067
A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease
NCT00615199
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease
NCT01751152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Blinded study arm
CCX282-B
CCX282-B or placebo capsules
2
Blinded study arm
CCX282-B
CCX282-B or placebo capsules
3
Blinded study arm
CCX282-B
CCX282-B or placebo capsules
4
Blinded study arm
CCX282-B
CCX282-B or placebo capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CCX282-B
CCX282-B or placebo capsules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CDAI 250-450
* CRP \>7.5
* signed written informed consent
Exclusion Criteria
* ileostomy, colostomy or rectal pouch
* diagnosis of ulcerative colitis or indeterminate colitis
* evidence of short bowel syndrome requiring enteral or parenteral supplementation or total parenteral nutrition
* hepatitis B, C or HIV infection
* history of infection requiring IV antibiotics
* serious or GI infection in the previous 12 weeks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD
Role: STUDY_DIRECTOR
Amgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bankstown - Lidcombe Hospital
Bankstown, New South Wales, Australia
Royal Brisbane and Womens Hospital
Herston, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
Launceston General Hospital
Launceston, Tasmania, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
St Vincents Hospital
Fitzroy, Victoria, Australia
Bayside Gastroenterology
Frankston, Victoria, Australia
Royal Melbourne Hospital
Parkville, Victoria, Australia
The Alfred Hospital
Prahran, Victoria, Australia
Fremantle Hospital
Fremantle, Western Australia, Australia
Universitätsklinik für Innere Medizin
Innsbruck, , Austria
A.ö. Krankenhaus der Elisabethinen Linz
Linz, , Austria
Landesklinikum St. Poelten
Pölten, , Austria
Krankenanstalt Rudolfstiftung
Vienna, , Austria
Universitätsklinik für Innere Medizin III
Vienna, , Austria
UZ Gent
Ghent, , Belgium
UZ Gasthuisberg
Leuven, , Belgium
Unigastro
Campinas, , Brazil
Centro Petropolitano de Reumatologia e Fisioterapia
Centro Petrópolis, , Brazil
Hospital das Clínicas de Curitiba UFPR
Curitiba, , Brazil
Hospital Geral de Goiânia
Goiânia, , Brazil
Instituto Goiano de Gastro
Goiânia, , Brazil
Hospital de Clínicas de Porto Alegre
Porto Alegre, , Brazil
Hospital São Lucas PUC-RS
Porto Alegre, , Brazil
Hospital Universitário Clementino Fraga Filho
Rio de Janeiro, , Brazil
Santo André Diagnósticos e tratamentoLtda.
Santo André, , Brazil
Irmandade da Santa Casa de Misericórdia de Santos
Santos, , Brazil
Irmandade da Santa Casa de Misericórdia de São Paulo
São Paulo, , Brazil
Hospital das Clínicas de São Paulo
São Paulo, , Brazil
Hospital Israelita Albert Einstein
São Paulo, , Brazil
4 MHAT, 38 "Makedonia" 1000
Sofia, , Bulgaria
Military Medical Academy
Sofia, , Bulgaria
UMHAT "Alexandrovska"
Sofia, , Bulgaria
UMHAT Queen Joanna
Sofia, , Bulgaria
UMHAT" St. Ivan Rilsky"
Sofia, , Bulgaria
V City Hospital
Sofia, , Bulgaria
UMHAT "St. Marina"
Varna, , Bulgaria
Health Science Centre
Calgary, Alberta, Canada
Lair Centre
Vancouver, British Columbia, Canada
DHC Research
Richmond Hill, Ontario, Canada
Mt. Sinai Hospital
Toronto, Ontario, Canada
Centre Hospitalier--Hotel-Dieu de Levis
Lévis, Quebec, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
CHAUQ-Hopital St-Sacrement
Québec, Quebec, Canada
Private Gastroenterology Centre
České Budejovice, , Czechia
Hepato-Gastroenterologie, Edvarda Benese 1549
Hradec Králové, , Czechia
II.Interni klinika, Endoskopie
Olomouc, , Czechia
Fakultni nemocnice
Prague, , Czechia
Klinika hepatogastroenterologieIKEM
Prague, , Czechia
General University Hospital Prague
Prague, , Czechia
Medic Kral ltd.
Prague, , Czechia
Regional Hospital Pribram
Příbram, , Czechia
Regional Hospital Tabor
Tábor, , Czechia
Medical Department V Århus University Hospital
Arhus C, , Denmark
Herlev Hospital Gastroenterologisk department
Herlev, , Denmark
Hvidovre Hospital
Hvidovre, , Denmark
Medical department S Odense University hospital
Odense, , Denmark
CHU Amiens - Hôpital Nord
Amiens, , France
Service d'Hépato-Gastroentérologie et de Nutrition Clinique
Nice, , France
Hopital du Haut-Lévêque
Pessac, , France
Hôpital Charles Nicolle
Rouen, , France
Service de Gastro-Enterologie et Nutrition
Toulouse, , France
Charité Campus Mitte, Universitätsmedizin Berlin
Berlin, , Germany
Medizinische Klinik m.S. Hepatologie, Gastroenterologie, Endokrinologie und Stoffwechsel
Berlin, , Germany
Fachärztin für Innere Medizin
Hamburg, , Germany
Klinikum der Christian-Albrechts-Universität zu Kiel
Kiel, , Germany
Universitätsklinikum Magdeburg A.ö.R
Magdeburg, , Germany
Gastroenterologische Praxis am Germania-Campus
Münster, , Germany
Klinikum der Universität Regensburg
Regensburg, , Germany
Réthy Pál Kórház
Békéscsaba, , Hungary
Fővárosi Önkormányzat Bajcsy-Zsilinszky Kórház
Budapest, , Hungary
Debreceni Egyetem OEC
Debrecen, , Hungary
Vaszary Kolos Kórház
Esztergom, , Hungary
Petz Aladár Megyei Oktató Kórház
Győr, , Hungary
BAZ Megyei Kórház
Miskolc, , Hungary
Soroka Medical Center
Beersheba, , Israel
Bnai Zion MC
Haifa, , Israel
Rambam Medical Center,
Haifa, , Israel
Hadassah Ein-Karem Medical Center
Jerusalem, , Israel
Meir Hospital
Kfar Saba, , Israel
Rabin Medical Center
Petah Tikva, , Israel
Kaplan Medical Center
Rehovot, , Israel
The Tel-Aviv Sourasky Medical Center
Tel Aviv, , Israel
Assaf Harofeh Medical Center
Trzifin, , Israel
Ringweg Randenbroek 110
Amersfoort, , Netherlands
Ikazia Ziekenhuis
Rotterdam, , Netherlands
Isala Klinieken Locatie Sophia Afd. Interne Geneeskunde
Zwolle, , Netherlands
ZOZ MSWiA Oddział Chorób Wewnętrznych
Bialystok, , Poland
10 Wojskowy Szpital Klinicznym, Oddzial Kliniczny Gasteroenterologii
Bydgoszcz, , Poland
SPZOZ Wojewodzki Szpital
Bydgoszcz, , Poland
Klinika Chorob Wewnetrznych I Gastroenterologii
Krakow, , Poland
Samodzielny Publiczny Szpital Kliniczny Nr 4
Lublin, , Poland
SPZOZ Szpital Wojewódzki w Opolu
Opole, , Poland
SOPMED Niepubliczny Zakład Opieki Zdrowotnej
Sopot, , Poland
Klinika Gastroenterologii i Chorób Wewnętrznych Samodzielny Publiczny Szpital Kliniczny nr 1 im. T. Sokołowskiego Pomorskiej Akademii Medycznej ul.Unii Lubelskiej 1
Szczecin, , Poland
NZOZ Vivamed Zespół Lekarzy Specjalistów ul. Trocka 10A
Warsaw, , Poland
CSK MSWiA, Klinika Gastroenterologii
Warsaw, , Poland
Wojskowy Insytutu Medyczny
Warsaw, , Poland
Klinika Gastroenterologii i Hepatologii, Akademii Medycznej
Wroclaw, , Poland
Panorama Medi Clinic
Cape Town, , South Africa
Louis Leipoldt Gastroenterology Centre, Louis Leipoldt Medical Centre
Cape Town, , South Africa
GastroEnterology Unit, Groote Schuur Hospital
Cape Town, , South Africa
Quatro Clinical Trial Institute
Cape Town, , South Africa
427 Ontdekkers Road, Florida Park
Johannesburg, , South Africa
Medicinkliniken, SU/Östra sjukhuset
Gothenburg, , Sweden
Universitetssjukhuset
Lund, , Sweden
Medicinmottagningen, Södersjukhuset
Stockholm, , Sweden
Sophiahemmet
Stockholm, , Sweden
Centre for Gastroenterology Royal Free Hospital
London, , United Kingdom
Dept of Gastroenterology, John Radcliffe Hospital
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Keshav S, Vanasek T, Niv Y, Petryka R, Howaldt S, Bafutto M, Racz I, Hetzel D, Nielsen OH, Vermeire S, Reinisch W, Karlen P, Schreiber S, Schall TJ, Bekker P; Prospective Randomized Oral-Therapy Evaluation in Crohn's Disease Trial-1 PROTECT-1 Study Group. A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease. PLoS One. 2013;8(3):e60094. doi: 10.1371/journal.pone.0060094. Epub 2013 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL004_282
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.